|Day Low/High||94.39 / 95.26|
|52 Wk Low/High||64.55 / 106.86|
From lollipops to locomotives, Warren Buffett's has a full buffet of topics to address Saturday.
While the two tobacco giants have similar yields, both also have very different businesses, with different growth potential in the years ahead.
Investors can gain exposure to the high-flying cannabis industry without taking on undue risks.
Tilray will not be cash flow positive for another 2-3 years - that's not quick enough progress for me given its $7 billion dollar capitalization.
Pot stocks like Tilray have very ambitious valuations but the potential upside (in mergers and, fundamentally in food, drink, supplemental and medical applications) are undeniably immense. The view of a possible rapid rise in revenues and profits (a...
The move was helped by the TLRY's deals with AB InBev for beverages and Novartis for medical applications.
Fear-mongering over risk of BBB credits was immensely exaggerated and hurt many people's returns.
This is one report where the real driver will be what the company says and the tone they take when saying it.
Even with its 12% stock decline on Wednesday, Constellation Brands is more intriguing than it was yesterday.
In the interest of due diligence, we went and took a close look at the ground floor of the newest investment craze.
For the first time in years we don't have to sacrifice quality to maintain income.
Establishing who the stragglers are and what impact they might have in the future is the key at this point.
I'd be most interested in buying this name after a cap raise which I expect in the first quarter of 2019.
Perhaps no company has bought into the Canadian cannabis craze more than Constellation Brands.
The buy-in from other companies into the space has been far larger.
Tilray's technical history is limited, but a bullish divergence in a key chart could be foreshadowing a rally ahead.
Pot stock partnerships are a gateway to gains for cannabis investors.
Let's take a look at the charts.
With so much going on in the markets, it's likely few people have had the time to connect these dots.
Even Buffett can bet on a bad horse.
It becomes difficult for me to tell you where to run in these markets...
These stocks offer some diversification or unique features in the legal-weed space.
It's too easy to lump all cannabis-related stocks into the moniker "marijuana." Like many other sectors, there are differentiators underneath the same way we see in semiconductors or retail or even energy. As you go down the marijuana rabbit hole, ...
Cannabis companies should be taking advantage of the mania to raise money.